All Articles

With strategic hires in AI and product, the health tech firm is doubling down on automating provider data, aiming to cut billions in waste and boost efficiency.

Post-divestment, Formula Systems posts record earnings and a hefty dividend, showcasing a masterclass in strategic portfolio management and growth.

NewBold's acquisition of Spencer Technologies isn't just a business deal. It's the blueprint for a single-source solution to retail's biggest tech headaches.

An industry veteran is bypassing boardrooms and targeting bookshelves, using a children's book to teach the next generation about proactive wildfire defense.

Innovation abounds, but getting on U.S. shelves is harder than ever. A dispatch from the Newtopia Now trade show reveals the operational gauntlet brands must run.

CrossCountry Mortgage just spent $1.28 billion to control your loan from start to finish. Is this a new industry blueprint or a debt-fueled risk for homeowners?

Amid housing market headwinds, Atlas Engineered Products posts a strong rebound, betting its future on a robotic factory and a strategy to rebuild the supply chain.

Kids In Need Foundation's massive 2026 effort reveals a masterclass in logistics and a stark look at how basic school supplies build confidence and equity.

The strategic acquisition combines engineered probiotics with CRISPR-based technology, creating a powerful new toolkit to revolutionize livestock health.

New data shows 84% of Americans needing substance use treatment don't get it. A new approach combines neuroscience and faith to rewire the brain for recovery.

Mitsubishi unveils its most ambitious US plan in decades, promising new EVs, a Nissan-built pickup, and rugged SUVs. But can it overcome a skeptical dealer network?

A Charlotte dog care brand's first franchise is more than a local story. It's a look at how tech, human capital, and smart incentives are transforming the $150B pet industry.

Allegheny Health Network and START's new partnership isn't just a local win; it's a blueprint for a more accessible, patient-centric future in oncology.

A new blood test can predict preterm birth risk months in advance, shifting prenatal care from reactive crisis to proactive strategy and saving billions.

A small biophysics firm unveils promising data for its at-home headset using magnetic fields to treat Long COVID, heralding a potential shift from pharma to biophysics.

A routine tender offer extension for a small healthcare operator reveals a larger story of a struggling company, a persistent buyer, and a new regulatory era.

Festool's integration of Shaper's handheld CNC tech is more than a merger; it's a blueprint for the future of woodworking. What does this mean for artisans?

A new partnership aims to bring AI and cloud tech to the Farm Credit System. What does this mean for farmers, rural economies, and the future of food?

As Lumexa Imaging execs hit the road for a four-conference tour, is it a victory lap for recent profits or a strategic play to manage debt and woo investors?

Quest Diagnostics is bringing longevity science to the masses with a new biological age test. Sandra Patterson explores the investment and ethical calculus.